1991
DOI: 10.1016/0002-9149(91)90200-5
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy and safety of sotalol in digitalized patients with chronic atrial fibrillation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
15
0
1

Year Published

2004
2004
2015
2015

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 77 publications
(16 citation statements)
references
References 11 publications
0
15
0
1
Order By: Relevance
“…Amiodarone has comparable rates of pharmacologic [18,19], but conversion during oral amiodarone loading is less common and often delayed [20]. Sotalol does not appear to be effective in terminating persistent AF/AFl [21,22]. Overall, the high rate of pharmacologic conversion observed with dofetilide in our study increases its desirability in the treatment of persistent AF/AFl as pharmacologic conversion obviates the risks associated with anesthesia and direct current cardioversion.…”
Section: Discussionmentioning
confidence: 65%
“…Amiodarone has comparable rates of pharmacologic [18,19], but conversion during oral amiodarone loading is less common and often delayed [20]. Sotalol does not appear to be effective in terminating persistent AF/AFl [21,22]. Overall, the high rate of pharmacologic conversion observed with dofetilide in our study increases its desirability in the treatment of persistent AF/AFl as pharmacologic conversion obviates the risks associated with anesthesia and direct current cardioversion.…”
Section: Discussionmentioning
confidence: 65%
“…Digoxin has few adverse effects after acute administration in therapeutic doses, aside from AV block and increased ventricular ectopy, but all manifestations of digitalis toxicity are dose related. 375,378,494,505,526,530,540,542 8.1.5.5.6. Disopyramide.…”
Section: Nondihydropyridine Calcium Channel Antagonists (Verapamil Anmentioning
confidence: 99%
“…Better HR control at rest18 27 3141 and exercise18 22 24 27 28 3144 is achieved with the combination of digoxin with a β-blocker. However, the effect of this combination on exercise tolerance is inconsistent, with some studies reporting deterioration in exercise capacity,31–33 35 41 some improvement26 36 39 and most no change 22 24 27 28 31 34 37 40 42 44…”
Section: β-Blockersmentioning
confidence: 99%
“…However, the effect of this combination on exercise tolerance is inconsistent, with some studies reporting deterioration in exercise capacity,31–33 35 41 some improvement26 36 39 and most no change 22 24 27 28 31 34 37 40 42 44…”
Section: β-Blockersmentioning
confidence: 99%